This Week in Startups

This Bittensor Subnet Could Cut Drug Discovery Costs in HALF | E2267

91 snips
Mar 26, 2026
Michaela Bazo, Metanova Labs co-founder, and Pedro Penna, technical lead in decentralized biotech, dive into Bittensor-powered drug discovery and the race to cut screening costs. Tom Bliers, BitCast Network co-founder, explores paying creators for watch time and branded videos. Max Septi, Score founder, shows how tiny vision AI models can make real-world deployment cheaper and faster.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Human Creators Still Beat AI Slop On BitCast

  • BitCast tries to suppress slop by tying rewards to engagement quality and brief accuracy, not upload volume.
  • Tom Bliers said early AI videos underperformed because viewers prefer people, and established creators protect their own reputations.
INSIGHT

Automation Unlocks The Long Tail Of Creators

  • Tom Bliers argued the creator economy is booming, but admin overhead pushes brands toward top creators and away from the long tail.
  • BitCast removes much of that coordination work, letting brands activate smaller trusted creators in many languages from one campaign.
ANECDOTE

BitCast Switched From Building To Scaling

  • BitCast says it shifted from building to scaling in 2026, reaching 50 creators with 2 million subscribers combined.
  • Tom Bliers said creator count is growing 40 to 50 percent monthly and watch time about 50 to 60 percent month over month.
Get the Snipd Podcast app to discover more snips from this episode
Get the app